ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹203 Cr | ₹179 Cr | ₹153 Cr | ₹161 Cr | ₹131 Cr |
What is the latest Total Current Liabilities ratio of ANUH PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹203 Cr |
| Mar2025 | ₹179 Cr |
| Mar2024 | ₹153 Cr |
| Mar2023 | ₹161 Cr |
| Mar2022 | ₹131 Cr |
How is Total Current Liabilities of ANUH PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹203 Cr | 13.72 | |
| Mar2025 | ₹179 Cr | 16.91 | |
| Mar2024 | ₹153 Cr | -5.36 | |
| Mar2023 | ₹161 Cr | 23.24 | |
| Mar2022 | ₹131 Cr | - | |
Compare Total Current Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹801.6 Cr | 4% | -10.8% | -4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 4% |
-10.8% |
-4% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses